Namely, our review presents that there is evidence supporting that hyperprolactinemia, excessive or defective GH, hypothyroidism, hypercortisolism, activation of the RAAS, PCOS, and hypogonadism are endocrine disorders that exert a negative/facilitative effect on NAFLD initiation or progression. The gene discussed is GH1; the disease is endocrine system disorder.